Barry E Greene's Net Worth

Barry E Greene's net worth is estimated to be at least $47,119,965.47 as of 10/01/2022. CoreStreet's estimation of Barry E Greene's net worth is based on their sale of stock and current holding of stock.

Barry E Greene is CEO at Sage Therapeutic. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 8,800 units of SAGE stock on 06/16/2021. Their biggest sale was on 10/02/2017 when they sold 85,316 units of Alnylam Pharmaceuticals Inc stock for $10,664,500.00. They typically trade 1 times per year.

Total value of insider buys:
  • $583,546.00
Total value of insider sells:
  • $46,536,419.47
Most recent insider trade:
  • June 16, 2021

Barry E Greene's Insider Trading History

Sage TherapeuticTitleAmountPriceTypeTotal Value
June 16, 2021
CEO8,800$56.32Buy$495,616.00
Alnylam Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Sept. 9, 2020
President44,530$123.23Sell$5,487,431.90
July 7, 2020
President22,265$159.99Sell$3,562,177.35
May 6, 2020
President22,265$149.99Sell$3,339,527.35
Oct. 22, 2019
President58,913$89.99Sell$5,301,580.87
March 14, 2018
President38,460$143.10Sell$5,503,626.00
Oct. 2, 2017
President85,316$125.00Sell$10,664,500.00
Sept. 20, 2017
President76,815$100.00Sell$7,681,500.00
Dec. 19, 2014
COO11,200$100.00Sell$1,120,000.00
Nov. 17, 2014
COO33,200$89.63Sell$2,975,716.00
May 28, 2013
COO22,822$30.00Sell$684,660.00
Acorda Therapeutics IncTitleAmountPriceTypeTotal Value
Aug. 1, 2017
Director10,000$21.57Sell$215,700.00
Karyopharm Therapeutics IncTitleAmountPriceTypeTotal Value
April 2, 2015
Director3,000$29.31Buy$87,930.00